Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-05-26

AUTHORS

M. Albertelli, E. Nazzari, S. Sciallero, F. Grillo, S. Morbelli, F. De Cian, G. Cittadini, E. Ambrosetti, A. Ciarmiello, D. Ferone, On behalf of the IRCCS Policlinico San Martino, University of Genova Neuroendocrine Tumor Board

ABSTRACT

Octreotide and lanreotide, the first-generation somatostatin analogs, successfully control hormone hyperproduction, and related syndromes, in patients with acromegaly and neuroendocrine tumors. However, their anti-tumor effect, rather evident in large number of pituitary adenomas in acromegalic patients, has been hypothesized for a long time in patients with neuroendocrine tumors as well, although a significant tumor shrinkage has rarely been observed. However, the recent publication of the CLARINET study has strengthened the evidence, already emerged with the PROMID trial, that the long-term treatment with the first-generation long-acting somatostatin analogs may exert an anti-tumor activity on G1 and G2 enteropancreatic neuroendocrine tumors, as well. After the publication, majority of international guidelines have updated their algorithms in line with these results and this class of drugs obtained the indication as anti-tumor agents in the majority of patients with neuroendocrine tumors. More... »

PAGES

1265-1269

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s40618-017-0692-0

DOI

http://dx.doi.org/10.1007/s40618-017-0692-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1085592770

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/28550464


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Clinical Trials as Topic", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuroendocrine Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Somatostatin", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Albertelli", 
        "givenName": "M.", 
        "id": "sg:person.01072154657.57", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072154657.57"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nazzari", 
        "givenName": "E.", 
        "id": "sg:person.01070341330.42", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070341330.42"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Oncology Unit, IRCCS Policlinico San Martino, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Oncology Unit, IRCCS Policlinico San Martino, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sciallero", 
        "givenName": "S.", 
        "id": "sg:person.01161347605.16", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161347605.16"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Pathology unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Pathology unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Grillo", 
        "givenName": "F.", 
        "id": "sg:person.0742523165.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742523165.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Nuclear Medicine Unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Nuclear Medicine Unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Morbelli", 
        "givenName": "S.", 
        "id": "sg:person.01143271075.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143271075.37"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Oncologic Surgery Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Oncologic Surgery Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Cian", 
        "givenName": "F.", 
        "id": "sg:person.01340317555.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340317555.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Radiology, IRCCS Policlinico San Martino, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department of Radiology, IRCCS Policlinico San Martino, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cittadini", 
        "givenName": "G.", 
        "id": "sg:person.016043177233.12", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016043177233.12"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ambrosetti", 
        "givenName": "E.", 
        "id": "sg:person.013037060407.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013037060407.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Nuclear Medicine, S. Andrea Hospital, La Spezia, Italy", 
          "id": "http://www.grid.ac/institutes/grid.415230.1", 
          "name": [
            "Department of Nuclear Medicine, S. Andrea Hospital, La Spezia, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ciarmiello", 
        "givenName": "A.", 
        "id": "sg:person.0717155232.03", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717155232.03"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Center of Excellence for Biomedical Research (CEBR), University of Genova, Genoa, Italy", 
          "id": "http://www.grid.ac/institutes/grid.5606.5", 
          "name": [
            "Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy", 
            "Center of Excellence for Biomedical Research (CEBR), University of Genova, Genoa, Italy"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ferone", 
        "givenName": "D.", 
        "id": "sg:person.0673454645.34", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673454645.34"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "On behalf of the IRCCS Policlinico San Martino, University of Genova Neuroendocrine Tumor Board", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1186/1756-9966-29-19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041424561", 
          "https://doi.org/10.1186/1756-9966-29-19"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.3275/7869", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078423857", 
          "https://doi.org/10.3275/7869"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-05-26", 
    "datePublishedReg": "2017-05-26", 
    "description": "Octreotide and lanreotide, the first-generation somatostatin analogs, successfully control hormone hyperproduction, and related syndromes, in patients with acromegaly and neuroendocrine tumors. However, their anti-tumor effect, rather evident in large number of pituitary adenomas in acromegalic patients, has been hypothesized for a long time in patients with neuroendocrine tumors as well, although a significant tumor shrinkage has rarely been observed. However, the recent publication of the CLARINET study has strengthened the  evidence, already emerged with the PROMID trial, that the long-term treatment with the first-generation long-acting somatostatin analogs may exert an anti-tumor activity on G1 and G2 enteropancreatic neuroendocrine tumors, as well. After the publication, majority of international guidelines have updated their algorithms in line with these results and this class of drugs obtained the indication as anti-tumor agents in the majority of patients with neuroendocrine tumors.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s40618-017-0692-0", 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.6856120", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1088396", 
        "issn": [
          "0391-4097", 
          "1720-8386"
        ], 
        "name": "Journal of Endocrinological Investigation", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "11", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "40"
      }
    ], 
    "keywords": [
      "neuroendocrine tumors", 
      "somatostatin analogues", 
      "CLARINET study", 
      "first-generation somatostatin analogues", 
      "significant tumor shrinkage", 
      "majority of patients", 
      "enteropancreatic neuroendocrine tumors", 
      "long-term treatment", 
      "anti-tumor effects", 
      "anti-tumoral effects", 
      "class of drugs", 
      "anti-tumor activity", 
      "anti-tumor agents", 
      "acromegalic patients", 
      "tumor shrinkage", 
      "pituitary adenomas", 
      "hormone hyperproduction", 
      "related syndromes", 
      "patients", 
      "international guidelines", 
      "tumors", 
      "acromegaly", 
      "lanreotide", 
      "syndrome", 
      "adenomas", 
      "majority", 
      "recent publications", 
      "trials", 
      "drugs", 
      "hyperproduction", 
      "treatment", 
      "study", 
      "indications", 
      "guidelines", 
      "effect", 
      "analogues", 
      "agents", 
      "G1", 
      "evidence", 
      "publications", 
      "long time", 
      "activity", 
      "large number", 
      "lines", 
      "number", 
      "time", 
      "results", 
      "shrinkage", 
      "lessons", 
      "class", 
      "algorithm"
    ], 
    "name": "Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study", 
    "pagination": "1265-1269", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1085592770"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s40618-017-0692-0"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "28550464"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s40618-017-0692-0", 
      "https://app.dimensions.ai/details/publication/pub.1085592770"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-12-01T06:36", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/article/article_745.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s40618-017-0692-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s40618-017-0692-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s40618-017-0692-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s40618-017-0692-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s40618-017-0692-0'


 

This table displays all metadata directly associated to this object as RDF triples.

225 TRIPLES      21 PREDICATES      83 URIs      73 LITERALS      12 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s40618-017-0692-0 schema:about N093a67211da641848834d475ce7ec551
2 N18cc9e71b1b049e1b15187957ffd9868
3 N3250c49a33ed41028090d278090fd3b1
4 N7da98b3c5973498b9502c6c299cfa942
5 Nad5bbfa3772949ebab80b4231daa4efb
6 anzsrc-for:11
7 anzsrc-for:1112
8 schema:author N64329de892614859a3c0930567e9803b
9 schema:citation sg:pub.10.1186/1756-9966-29-19
10 sg:pub.10.3275/7869
11 schema:datePublished 2017-05-26
12 schema:datePublishedReg 2017-05-26
13 schema:description Octreotide and lanreotide, the first-generation somatostatin analogs, successfully control hormone hyperproduction, and related syndromes, in patients with acromegaly and neuroendocrine tumors. However, their anti-tumor effect, rather evident in large number of pituitary adenomas in acromegalic patients, has been hypothesized for a long time in patients with neuroendocrine tumors as well, although a significant tumor shrinkage has rarely been observed. However, the recent publication of the CLARINET study has strengthened the evidence, already emerged with the PROMID trial, that the long-term treatment with the first-generation long-acting somatostatin analogs may exert an anti-tumor activity on G1 and G2 enteropancreatic neuroendocrine tumors, as well. After the publication, majority of international guidelines have updated their algorithms in line with these results and this class of drugs obtained the indication as anti-tumor agents in the majority of patients with neuroendocrine tumors.
14 schema:genre article
15 schema:isAccessibleForFree false
16 schema:isPartOf N05e2125293ad440482c71eb1a321dac3
17 N2d540b2d316f457da935ef5a020b6c7f
18 sg:journal.1088396
19 schema:keywords CLARINET study
20 G1
21 acromegalic patients
22 acromegaly
23 activity
24 adenomas
25 agents
26 algorithm
27 analogues
28 anti-tumor activity
29 anti-tumor agents
30 anti-tumor effects
31 anti-tumoral effects
32 class
33 class of drugs
34 drugs
35 effect
36 enteropancreatic neuroendocrine tumors
37 evidence
38 first-generation somatostatin analogues
39 guidelines
40 hormone hyperproduction
41 hyperproduction
42 indications
43 international guidelines
44 lanreotide
45 large number
46 lessons
47 lines
48 long time
49 long-term treatment
50 majority
51 majority of patients
52 neuroendocrine tumors
53 number
54 patients
55 pituitary adenomas
56 publications
57 recent publications
58 related syndromes
59 results
60 shrinkage
61 significant tumor shrinkage
62 somatostatin analogues
63 study
64 syndrome
65 time
66 treatment
67 trials
68 tumor shrinkage
69 tumors
70 schema:name Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study
71 schema:pagination 1265-1269
72 schema:productId N321477db978f427b85b28645d210b174
73 N6b6c3710cfae4d4490661cd3b84cdebf
74 Nbea3c203fb2449e48f1edf9ad722df23
75 schema:sameAs https://app.dimensions.ai/details/publication/pub.1085592770
76 https://doi.org/10.1007/s40618-017-0692-0
77 schema:sdDatePublished 2022-12-01T06:36
78 schema:sdLicense https://scigraph.springernature.com/explorer/license/
79 schema:sdPublisher N88ecd69893604d64bdb4d2bee7aceee5
80 schema:url https://doi.org/10.1007/s40618-017-0692-0
81 sgo:license sg:explorer/license/
82 sgo:sdDataset articles
83 rdf:type schema:ScholarlyArticle
84 N05e2125293ad440482c71eb1a321dac3 schema:issueNumber 11
85 rdf:type schema:PublicationIssue
86 N093a67211da641848834d475ce7ec551 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Antineoplastic Agents
88 rdf:type schema:DefinedTerm
89 N0b752918162948f7a82d8f1d4f29d3ca rdf:first sg:person.01143271075.37
90 rdf:rest Nd233e58bb0f043c481617dae108185fa
91 N18cc9e71b1b049e1b15187957ffd9868 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
92 schema:name Neuroendocrine Tumors
93 rdf:type schema:DefinedTerm
94 N1ecde242da0946fe912e4b04c352ceb4 rdf:first sg:person.016043177233.12
95 rdf:rest N272e26e2c58b4660af8b1226512a7a1c
96 N272e26e2c58b4660af8b1226512a7a1c rdf:first sg:person.013037060407.24
97 rdf:rest N62888e3535f24967b32e4acf4860a40e
98 N2d540b2d316f457da935ef5a020b6c7f schema:volumeNumber 40
99 rdf:type schema:PublicationVolume
100 N321477db978f427b85b28645d210b174 schema:name doi
101 schema:value 10.1007/s40618-017-0692-0
102 rdf:type schema:PropertyValue
103 N3250c49a33ed41028090d278090fd3b1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Clinical Trials as Topic
105 rdf:type schema:DefinedTerm
106 N49c6b4869bd3478ba54ed84fe5b8047e rdf:first sg:person.01070341330.42
107 rdf:rest Necc38bfc44f84574b44cd73553c8f2bb
108 N62888e3535f24967b32e4acf4860a40e rdf:first sg:person.0717155232.03
109 rdf:rest N7da33cde199b41d6b9702b19de6410a9
110 N64329de892614859a3c0930567e9803b rdf:first sg:person.01072154657.57
111 rdf:rest N49c6b4869bd3478ba54ed84fe5b8047e
112 N6b6c3710cfae4d4490661cd3b84cdebf schema:name pubmed_id
113 schema:value 28550464
114 rdf:type schema:PropertyValue
115 N7da33cde199b41d6b9702b19de6410a9 rdf:first sg:person.0673454645.34
116 rdf:rest Nfde6d3af368646fd828c0e7e75bf04f6
117 N7da98b3c5973498b9502c6c299cfa942 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Humans
119 rdf:type schema:DefinedTerm
120 N88ecd69893604d64bdb4d2bee7aceee5 schema:name Springer Nature - SN SciGraph project
121 rdf:type schema:Organization
122 N96826115a992433c97317f3c2a573d9f schema:familyName On behalf of the IRCCS Policlinico San Martino, University of Genova Neuroendocrine Tumor Board
123 rdf:type schema:Person
124 N96acaaaaf8a84f58aacdd276bfe0f5af rdf:first sg:person.0742523165.81
125 rdf:rest N0b752918162948f7a82d8f1d4f29d3ca
126 Nad5bbfa3772949ebab80b4231daa4efb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
127 schema:name Somatostatin
128 rdf:type schema:DefinedTerm
129 Nbea3c203fb2449e48f1edf9ad722df23 schema:name dimensions_id
130 schema:value pub.1085592770
131 rdf:type schema:PropertyValue
132 Nd233e58bb0f043c481617dae108185fa rdf:first sg:person.01340317555.31
133 rdf:rest N1ecde242da0946fe912e4b04c352ceb4
134 Necc38bfc44f84574b44cd73553c8f2bb rdf:first sg:person.01161347605.16
135 rdf:rest N96acaaaaf8a84f58aacdd276bfe0f5af
136 Nfde6d3af368646fd828c0e7e75bf04f6 rdf:first N96826115a992433c97317f3c2a573d9f
137 rdf:rest rdf:nil
138 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
139 schema:name Medical and Health Sciences
140 rdf:type schema:DefinedTerm
141 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
142 schema:name Oncology and Carcinogenesis
143 rdf:type schema:DefinedTerm
144 sg:grant.6856120 http://pending.schema.org/fundedItem sg:pub.10.1007/s40618-017-0692-0
145 rdf:type schema:MonetaryGrant
146 sg:journal.1088396 schema:issn 0391-4097
147 1720-8386
148 schema:name Journal of Endocrinological Investigation
149 schema:publisher Springer Nature
150 rdf:type schema:Periodical
151 sg:person.01070341330.42 schema:affiliation grid-institutes:grid.5606.5
152 schema:familyName Nazzari
153 schema:givenName E.
154 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01070341330.42
155 rdf:type schema:Person
156 sg:person.01072154657.57 schema:affiliation grid-institutes:grid.5606.5
157 schema:familyName Albertelli
158 schema:givenName M.
159 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01072154657.57
160 rdf:type schema:Person
161 sg:person.01143271075.37 schema:affiliation grid-institutes:grid.5606.5
162 schema:familyName Morbelli
163 schema:givenName S.
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01143271075.37
165 rdf:type schema:Person
166 sg:person.01161347605.16 schema:affiliation grid-institutes:None
167 schema:familyName Sciallero
168 schema:givenName S.
169 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01161347605.16
170 rdf:type schema:Person
171 sg:person.013037060407.24 schema:affiliation grid-institutes:grid.5606.5
172 schema:familyName Ambrosetti
173 schema:givenName E.
174 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013037060407.24
175 rdf:type schema:Person
176 sg:person.01340317555.31 schema:affiliation grid-institutes:grid.5606.5
177 schema:familyName De Cian
178 schema:givenName F.
179 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340317555.31
180 rdf:type schema:Person
181 sg:person.016043177233.12 schema:affiliation grid-institutes:None
182 schema:familyName Cittadini
183 schema:givenName G.
184 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016043177233.12
185 rdf:type schema:Person
186 sg:person.0673454645.34 schema:affiliation grid-institutes:grid.5606.5
187 schema:familyName Ferone
188 schema:givenName D.
189 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0673454645.34
190 rdf:type schema:Person
191 sg:person.0717155232.03 schema:affiliation grid-institutes:grid.415230.1
192 schema:familyName Ciarmiello
193 schema:givenName A.
194 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0717155232.03
195 rdf:type schema:Person
196 sg:person.0742523165.81 schema:affiliation grid-institutes:grid.5606.5
197 schema:familyName Grillo
198 schema:givenName F.
199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0742523165.81
200 rdf:type schema:Person
201 sg:pub.10.1186/1756-9966-29-19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041424561
202 https://doi.org/10.1186/1756-9966-29-19
203 rdf:type schema:CreativeWork
204 sg:pub.10.3275/7869 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078423857
205 https://doi.org/10.3275/7869
206 rdf:type schema:CreativeWork
207 grid-institutes:None schema:alternateName Department of Radiology, IRCCS Policlinico San Martino, Genoa, Italy
208 Medical Oncology Unit, IRCCS Policlinico San Martino, Genoa, Italy
209 schema:name Department of Radiology, IRCCS Policlinico San Martino, Genoa, Italy
210 Medical Oncology Unit, IRCCS Policlinico San Martino, Genoa, Italy
211 rdf:type schema:Organization
212 grid-institutes:grid.415230.1 schema:alternateName Department of Nuclear Medicine, S. Andrea Hospital, La Spezia, Italy
213 schema:name Department of Nuclear Medicine, S. Andrea Hospital, La Spezia, Italy
214 rdf:type schema:Organization
215 grid-institutes:grid.5606.5 schema:alternateName Center of Excellence for Biomedical Research (CEBR), University of Genova, Genoa, Italy
216 Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy
217 Nuclear Medicine Unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy
218 Oncologic Surgery Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genoa, Italy
219 Pathology unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy
220 schema:name Center of Excellence for Biomedical Research (CEBR), University of Genova, Genoa, Italy
221 Endocrinology Unit, Department of Internal Medicine (DiMI), University of Genova, Genoa, Italy
222 Nuclear Medicine Unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy
223 Oncologic Surgery Unit, Department of Surgical Sciences and Integrated Diagnostics (DISC), University of Genova, Genoa, Italy
224 Pathology unit, Department of Health Science (DiSSAL), University of Genova, Genoa, Italy
225 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...